ArticleJournal for immunotherapy of cancer2023

Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis.

Nian Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.